While trying to determine the anti-metastatic effects of FAM46C in HCC cells, the authors found that FAM46C expression and down-modulation were inhibiting or favouring, respectively, the phosphorylation of SMAD2/3, a downstream target of TGF-β. Here, TGFB1 is linked to hepatocellular carcinoma.